Vertebroplasty appears to be safe for people in their golden years, but as the range of applications expands and the age of eligibility grows younger, will the procedure stand the test of time? A new study of goats suggests it will.
Vertebroplasty appears to be safe for people in their golden years, but as the range of applications expands and the age of eligibility grows younger, will the procedure stand the test of time? A new study of goats suggests it will.
Dr. Jorrit Jan Verlaan, an orthopedic surgery resident from the University Medical Center in Utrecht, the Netherlands, examined the effect of two types of cement in traumatic fracture treatment, which is commonly performed in younger patients. Results were presented at the 2006 European Congress of Radiology.
Thirty animals underwent bilateral transpedicular vertebroplasty at two lumbar levels. Animals were injected with either polymethylmethacrylate or calcium phosphate cement, with and without direct contact with intervertebral material.
Follow-up at six months revealed no signs of disc or endplate degeneration and no decrease in the mean disc height. Overall, the study results are reassuring, given that vertebroplasty has been booming in popularity, said Verlaan. But he also sounded a cautionary note.
"A lot of promising techniques are being introduced into the clinic without appropriate trials. We should be very careful. Applications are rapidly expanding for vertebroplasty without any data on long-term effects," he said.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.